However, TRIB1 has been associated with the development and progression of a number of solid tumour types, including breast cancer [21,39], hepatocellular carcinoma [38], glioma [45], gastric cancer [61], prostate cancer [62,63] and colorectal cancer [33]. Here, TRIB1 is linked to Familial prostate cancer.